|
Age (per year)
|
1.00 (0.98–1.03)
|
0.73
|
–
|
–
|
|
Diabetes duration (per year)
|
1.00 (0.98–1.02)
|
0.71
|
–
|
–
|
|
Sex (women)
|
1.5 (0.9–2.5)
|
0.14
|
–
|
–
|
|
Depression
|
6.5 (1.5–28.0)
|
0.012
|
7.1 (1.6–31.4)
|
0.009
|
|
High galectin-3 (≥2.6 ng/ml)
|
0.8 (0.4–1.6)
|
0.49
|
–
|
–
|
|
High HbA1c (> 70 mmol/mol (> 8.6%))
|
1.0 (0.6–1.8)
|
0.91
|
–
|
–
|
|
Total cholesterol (mmol/l)
|
1.2 (0.9–1.6)
|
0.19
|
–
|
–
|
|
LDL (mmol/l)
|
1.2 (0.9–1.7)
|
0.29
|
–
|
–
|
|
Triglycerides (mmol/l)
|
1.3 (0.9–2.0)
|
0.18
|
–
|
–
|
|
HDL (mmol/l)
|
0.8 (0.4–1.7)
|
0.60
|
–
|
–
|
|
Triglycerides/HDL-cholesterol ratio
|
1.5 (0.9–2.6)
|
0.11
|
–
|
–
|
|
S-Creatinine (μmol/l)
|
1.00 (0.98–1.01)
|
0.63
|
–
|
–
|
|
Abdominal obesity
|
1.4 (0.6–2.8)
|
0.42
|
–
|
–
|
|
BMI (per kg/m2)
|
0.7 (0.4–1.3)
|
0.26
|
–
|
–
|
|
Systolic BP (mm Hg)
|
1.01 (0.99–1.03)
|
0.33
|
–
|
–
|
|
Diastolic BP (mm Hg)
|
1.00 (0.96–1.03)
|
0.63
|
–
|
–
|
|
Hypoglycemia (severe episodes)
|
0.7 (0.2–2.6)
|
0.64
|
–
|
–
|
|
Smoking
|
1.0 (0.4–2.5)
|
0.92
|
–
|
–
|
|
Physical inactivity
|
2.1 (0.8–5.9)
|
0.14
|
–
|
–
|
|
Continuous subcutaneous insulin infusion
|
0.3 (0.1–0.7)
|
0.004
|
0.3 (0.1–0.6)
|
0.003
|
|
Antidepressants users
|
1.1 (0.4–3.0)
|
0.78
|
–
|
–
|
|
Lipid lowering drugs
|
1.2 (0.7–2.0)
|
0.56
|
–
|
–
|
|
Antihypertensive drugs
|
1.0 (0.6–1.8)
|
0.94
|
–
|
–
|
|
Cardiovascular complications
|
1.7 (0.4–8.3)
|
0.49
|
–
|
–
|
